HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term results of hepatectomy after hepatic arterial infusion chemotherapy for initially unresectable hepatic colorectal metastases.

AbstractBACKGROUND:
The prognosis of unresectable hepatic colorectal metastases is poor even if chemotherapy is administered. The purpose of this study was to evaluate the long-term efficacy of hepatic arterial infusion (HAI) chemotherapy and hepatectomy following HAI for such condition.
METHODS:
Seventy-two patients with unresectable hepatic colorectal metastases received continuous HAI of 5-fluorouracil.
RESULTS:
The overall response rate was 38%. The median survival of all patients was 18 months. The overall 3-year survival rate was 18%. Seven patients (10%) survived more than 58 months. Of the eight patients with a complete response, seven developed liver and/or lung metastases, and of these, one patient undergoing additional hepatectomy has been disease-free and the other six receiving chemotherapy died of disease. Another complete-response case died of liver abscess. Of the 19 patients with a partial response, six could undergo hepatectomy after HAI. The overall 5-year survival rate of seven patients undergoing hepatectomy was 71%, whereas for patients without hepatectomy, the rate was 0%.
CONCLUSIONS:
Most patients showing response after HAI for unresectable hepatic colorectal metastases had relapses. The long-term prognosis of patients undergoing hepatectomy after HAI was favorable. Therefore, when HAI makes liver metastases resectable, they should be resected.
AuthorsYoshiya Fujimoto, Takayuki Akasu, Seiichiro Yamamoto, Shin Fujita, Yoshihiro Moriya
JournalJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (J Gastrointest Surg) Vol. 13 Issue 9 Pg. 1643-50 (Sep 2009) ISSN: 1873-4626 [Electronic] United States
PMID19582514 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fluorouracil
Topics
  • Adult
  • Aged
  • Colorectal Neoplasms (mortality, pathology, therapy)
  • Combined Modality Therapy
  • Disease-Free Survival
  • Female
  • Fluorouracil (administration & dosage)
  • Hepatectomy (methods, mortality)
  • Humans
  • Infusions, Intra-Arterial
  • Kaplan-Meier Estimate
  • Liver Neoplasms (mortality, secondary, therapy)
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Probability
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Statistics, Nonparametric
  • Survival Analysis
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: